Data Analytics Finds Disparities in Pregnancy Outcomes

Data analytics shows that ethnic and racial minority patients with systemic lupus erythematosus are disproportionately affected when it comes to pregnancy outcomes, despite the improvements seen over the last couple of years.

In a press release, Bella Mehta, a rheumatologist at Hospital for Special Surgery and the lead author of a recent study, stated that these improvements were more apparent in some groups in comparison to others, explaining that Hispanics and African Americans still had poor pregnancy outcomes. Mehta noted that more research was needed to determine where resources were required to improve care and access for these patients.

For their study, the researchers collected data from the National Inpatient Sample to carry out a retrospective cross-sectional analysis of lupus and pregnancy-related admissions in the period 2008–17. The researchers then examined the pregnancy and population health outcomes for Hispanic, Black, White and Native American/Asian/Other women, which included Cesarean section, non-delivery-related admissions, fetal mortality and in-hospital maternal mortality.

They discovered that during the study period, there were slightly more than 61,000 pregnancy-related hospitalizations, with the median age of pregnant women included in the sample being 31 for Native American/Asian/other women, 30 for Caucasian women, and 29 for Hispanic and Black women. The researchers also found that in comparison to the other two groups, Hispanic and Black women were most likely to be on Medicaid.

They also observed that Cesarean-section and fetal-mortality rates as well as non-delivery-related admissions reduced among all ethnic/racial groups, noting that rates of maternal mortality were low during the study period.

The scientists also discovered that Native American/Asian/other populations had the least fetal mortality, while Black women had the highest rates of fetal mortality in comparison to the Caucasian or Hispanic women. Data also showed that Black women had the highest rates of Cesarean sections and non-delivery admissions when compared to the other groups.

Lisa R. Sammaritano, who is coauthor of the study and a rheumatologist at the healthcare institution, stated that research had shown that women with lupus could get pregnant if they had quiet disease activity at conception, adding that if they had severe internal organ damage, it wasn’t advisable to conceive.

Sammaritano also noted that the study demonstrated that there still existed a disparity between Caucasian women and non-Caucasian ethnic groups with regard to pregnancy outcomes in patients with lupus; however, she asserted that there was still improvement in both groups, as seen in the last decade. The rheumatologist argued that it was crucial that researchers identify why these disparities existed.

The presence of companies with data analytics platforms, such as RYAH Group Inc. (CSE: RYAH), is likely to draw attention to additional insights about healthcare systems around the world, and policymakers will have the information they need to make the best decisions when planning for the healthcare system.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://ibn.fm/RYAH

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.